Purchases and Sales Made in Q1 2022 in Iovance Biotherapeutics, Inc. (IOVA)
This table provides information about the institutional ownership of Iovance Biotherapeutics, Inc. (IOVA) during Q1 2022. The information is specifically focused on institutions that hold shares of IOVANCE BIOTHERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 16, 2022
Q1 2022
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-810K- 94.08% |
$10M - $15.5M
|
51K
$399K
|
|
|
May 16, 2022
Q1 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-875K- 60.38% |
$10.8M - $16.7M
|
574K
$4.5M
|
|
|
Oct 27, 2022
Q1 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-891K- 61.47% |
$11M - $17M
|
559K
$4.38M
|
|
|
May 09, 2022
Q1 2022
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-1.3MClosed |
$16.1M - $24.9M
|
0
$0
|
|
|
May 12, 2023
Q1 2022
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-1.62M- 54.49% |
$20.1M - $31M
|
1.35M
$10.6M
|
|
|
May 13, 2022
Q1 2022
|
Frazier Management LLC
Seattle, WA |
SELL
|
- |
-1.75MClosed |
$21.6M - $33.4M
|
0
$0
|
|
|
May 06, 2022
Q1 2022
|
Nikko Asset Management Americas, Inc.
|
SELL
|
- |
-2.59M- 52.1% |
$32M - $49.4M
|
2.38M
$18.6M
|
|
|
Apr 27, 2022
Q1 2022
|
Sumitomo Mitsui Trust Holdings, Inc.
|
SELL
|
- |
-2.59M- 52.1% |
$32M - $49.4M
|
2.38M
$18.6M
|
|
|
May 16, 2022
Q1 2022
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-3MClosed |
$37.1M - $57.3M
|
0
$0
|
|
|
Apr 19, 2022
Q1 2022
|
Cathie Wood
Ark Investment Management LLC | St. Petersburg, Fl
|
SELL
|
- |
-4.16M- 57.82% |
$51.6M - $79.5M
|
3.04M
$23.8M
|